Pharmaceutical Drug Delivery Market - By Route Of Administration (Oral, Injectable, Self-Injectors, Topical, Pulmonary, Nasal, Transmucosal), By Application, Facility Of Use (Hospitals, Clinics, Home Care Settings, Diagnostic Centers) - Global Forecast to 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationPharmaceutical Drug Delivery Market - By Route Of Administration (Oral, Injectable, Self-Injectors, Topical, Pulmonary, Nasal, Transmucosal), By Application, Facility Of Use (Hospitals, Clinics, Home Care Settings, Diagnostic Centers) - Global Forecast to 2032
Pharmaceutical Drug Delivery Market Size
Pharmaceutical Drug Delivery Market size was more than USD 1.6 trillion in 2022 and is forecast to observe more than 7% CAGR from 2023 to 2032. The rising adoption of self-administration and home care will influence the market development.
Hey there! People are getting smarter about taking care of themselves and choosing to stay home rather than going to the hospital. It's more affordable and convenient, especially for our older folks. With so many folks living with conditions like diabetes, there's a huge demand for devices that help people give themselves shots at home. This saves them a ton of money on hospital visits and caregivers. So, companies are jumping on the bandwagon and creating new products to meet this need. For example, Jabil Healthcare just came out with a cool device called the Qfinity Autoinjector Platform. It's reusable and makes giving yourself shots a breeze.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Pharmaceutical Drug Delivery Market Size in 2022 | USD 1.64 Trillion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 7.1% |
| 2032 Value Projection | USD 3.2 Trillion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 850 |
| Tables, Charts & Figures | 1,673 |
| Segments covered | Route of administration, Application, Facility of use, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Concerns over needlestick injuries could hamper the growth of the pharmaceutical drug delivery market. Injuries from needlesticks happen when a needle inadvertently pierces the skin. Such wounds are dangerous because they can spread bacteria that can result in deadly bloodborne diseases. As per estimates, around 600,000 to 800,000 needlestick injuries are recorded in the US each year. Healthcare workers are at high risk of needlestick injuries which can lead to serious or fatal infections.
Pharmaceutical Drug Delivery Market Analysis
Hey there! The market for drug delivery through injections is expected to grow by about 7.4% every year from 2023 to 2032. There are two main types of these devicestraditional injections and self-injection devices. During the COVID-19 pandemic, these devices became super popular for vaccines. But they're also commonly used for treating diseases like diabetes, cancer, and heart problems. As more and more people live with chronic illnesses, the demand for these products is going to keep growing around the world. That's why drug companies are busy building more factories to make these injectable drug delivery products. For example, in October 2022, a company called Eisai opened a brand-new factory for these devices worth a whopping $69 million! They even built a special building to invent new products in this field.
Infectious diseases are on the rise around the world, with conditions like SARS, swine flu, and TB becoming more common. As a result, the market for drugs that treat these infections is expected to grow rapidly over the next decade, reaching over $555 billion by 2032. Traditionally, infectious diseases have been treated with oral or injectable drugs. However, climate change and new viruses like COVID-19 are putting a strain on our healthcare systems, making effective drug delivery more important than ever. According to the Centers for Disease Control (CDC), diseases like the West Nile virus, Lyme disease, and valley fever have spread significantly in recent years. These infections highlight the need for innovative drug delivery solutions that can effectively combat the growing threat of infectious diseases.
Pharmaceutical drug delivery market share from the hospitals segment is expected to reach over USD 1.8 trillion by 2032. This growth will be accelerated by the large patient population visiting hospitals for a range of diseases. Hospitals also provide a wide range of medical services to patients, which accelerates market growth. The advanced infrastructure and medical devices present in hospitals attract more patients. The development of cutting-edge technologies and the presence of highly skilled professionals will influence market growth over the coming years.
North America pharmaceutical drug delivery market share was nearly 49% in 2022. Alcohol consumption, smoking, and sedentary behavior are all contributing to an increase in cases of diseases, which will support market expansion. Additionally, the region is home to a significant number of well-known pharmaceutical brands. Multiple hospitals and other healthcare facilities are in abundance in the region. Furthermore, high healthcare expenditures and expanding government initiatives to support improvement in healthcare sector is expected to endorse pharmaceutical drug delivery companies in the region.
Pharmaceutical Drug Delivery Market Share
- Johnson & Johnson
- AstraZeneca plc
- AbbVie Inc
- Bayer AG
- Amgen Inc
- Eli Lilly and Company
- Sanofi
- Merck & Co Inc.
- GILEAD SCIENCES, INC.,
- Pfizer Inc.
are some of the key players in the global pharmaceutical drug delivery market. Initiatives by the companies like partnerships, collaborations, and new product launches are expected to increase market growth over the years. For instance, in March 2023, Sanofi reduced the cost of their popular insulin Lantus by 78% with a cap of USD 35 in order to make the out-of-pocket drugs more affordable for all patients with commercial insurance.
The pharmaceutical drug delivery market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments Click here to Buy Section of this Report
By Route of Administration
- Oral drug delivery
- Solid oral drugs
- Tablets
- Capsules
- Powders
- Pills
- Liquid oral drugs
- Syrups
- Solutions
- Semi solid oral drugs
- Gels
- Emulsions
- Elixirs
- Solid oral drugs
- Injectable drug delivery
- Conventional injection devices
- By material
- Glass syringes
- Plastic syringes
- By Product
- Fillable syringes
- Prefilled syringes
- By Usability
- Reusable syringes
- Disposable syringes
- By material
- Self-injection devices
- Needle-free injectors
- Autoinjectors
- Pen injectors
- Wearable injectors
- Other injector devices
- Conventional injection devices
- Topical drug delivery
- Liquid formulations
- Solutions
- Suspensions
- Semi-solid formulations
- Creams
- Gels
- Ointments
- Pastes
- Lotions
- Solid formulations
- Suppositories
- Powders
- Transdermal products
- Transdermal patches
- Transdermal gels
- Liquid formulations
- Ocular drug delivery
- Liquid formulations
- Eye drops
- Liquid sprays
- Semisolid formulations
- Gels
- Eye ointments
- Ocular devices
- Drug-coated contact lenses
- Ocular inserts
- Liquid formulations
- Pulmonary drug delivery
- Metered-dose inhalers
- Dry powder inhalers
- Nebulizers
- Jet nebulizers
- Ultrasonic nebulizers
- Soft mist nebulizers
- Nasal drug delivery
- Nasal drops
- Nasal sprays
- Nasal powders
- Nasal gels
- Transmucosal drug delivery
- Oral formulations
- Buccal drug delivery
- Sublingual drug delivery
- Other transmucosal drug delivery technologies
- Rectal drug delivery
- Vaginal drug delivery
- Oral formulations
- Implantable drug delivery
- Active implantable drug delivery
- Passive implantable drug delivery
By Application
- Infectious diseases
- Cancer
- Cardiovascular diseases
- Diabetes
- Respiratory diseases
- Central nervous system disorders
- Autoimmune diseases
- Other applications
By Facility of Use
- Hospitals
- Ambulatory surgical centers and clinics
- Home care settings
- Diagnostic centers
- Other facilities of use
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Switzerland
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy